Evan Leitner is an associate in Cooley's business practice department and focuses on general corporate law.
Download full bio
Morphic Therapeutics - $104 Million IPO
Akero Therapeutics - $106 Million IPO
Bicycle Therapeutics - $61 Million IPO
New York University School of LawJD, 2015
Yale UniversityBA, 2009
Not admitted to practice in Massachusetts